A Phase 3, Randomized, Study of Neoadjuvant Chemotherapy alone versus Neoadjuvant Chemotherapyplus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Post-Surgery Therapy withNivolumab or Nivolumab and BMS-986205 in Participants with

  • Gupta, Shilpa, (PI)

Project: Research project

Description

A Phase 3, Randomized, Study of Neoadjuvant Chemotherapy alone versus Neoadjuvant Chemotherapy plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Post-Surgery Therapy with Nivolumab or Nivolumab and BMS-986205 in Participants with
StatusActive
Effective start/end date11/1/1811/30/23

Funding

  • BRISTOL-MYERS SQUIBB COMPANY

Fingerprint

Drug Therapy
Therapeutics
nivolumab